xaliproden has been researched along with Colorectal Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
D'Orazio, A; Gibson, TB; Ranganathan, A | 1 |
1 other study(ies) available for xaliproden and Colorectal Neoplasms
Article | Year |
---|---|
Highlights From: the 2006 American Society of Clinical Oncology Gastrointestinal Cancers Symposium San Francisco, CA, January 2006.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Clinical Trials as Topic; Colorectal Neoplasms; Drug-Related Side Effects and Adverse Reactions; Gastrointestinal Neoplasms; Humans; Naphthalenes; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Pyridines; Serotonin Receptor Agonists | 2006 |